Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipodystrophy Syndrome, HIV”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Testing effectiveness (Phase 2)Study completedNCT00367744
What this trial is testing

Rosiglitazone Effect on Mitochondria and Lipoatrophy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 71
Not applicableStudy completedNCT00312832
What this trial is testing

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV InfectionsLipoatrophy
Hospital Clinic of Barcelona 60
Post-approval studies (Phase 4)Study completedNCT01612858
What this trial is testing

Metabolic Abnormalities in HIV-infected Persons

Who this might be right for
LipodystrophyHIV Infection
Tufts Medical Center 20
Post-approval studies (Phase 4)Study completedNCT03226821
What this trial is testing

Body Composition and Adipose Tissue in HIV

Who this might be right for
HIV Lipodystrophy SyndromeGrowth Hormone DeficiencyBody Composition
Columbia University 5
Not applicableStudy completedNCT00006290
What this trial is testing

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT01511016
What this trial is testing

Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

Who this might be right for
HIV Lipodystrophy
Baylor College of Medicine 17
Not applicableStudy completedNCT01359917
What this trial is testing

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
NHS Lothian 50
Large-scale testing (Phase 3)Study completedNCT00307164
What this trial is testing

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

Who this might be right for
HIV InfectionsLipoatrophy
National Institute of Allergy and Infectious Diseases (NIAID) 167
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Not applicableStudy completedNCT00100698
What this trial is testing

Physiologic Growth Hormone Effects in HIV Lipodystrophy

Who this might be right for
AIDSHIV Infections
Massachusetts General Hospital 56
Post-approval studies (Phase 4)Study completedNCT00135356
What this trial is testing

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Bristol-Myers Squibb 219
Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Post-approval studies (Phase 4)Study completedNCT00389194
What this trial is testing

PREventing Progression of Adipose Tissue Redistribution

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 120
Post-approval studies (Phase 4)Study completedNCT00227500
What this trial is testing

Pravastatin for Hyperlipidaemia in HIV.

Who this might be right for
HIV InfectionsLipid MetabolismGlucose Metabolism+3 more
Kirby Institute 40
Post-approval studies (Phase 4)Study completedNCT00389402
What this trial is testing

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 120
Not applicableUnknownNCT04887675
What this trial is testing

Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI

Who this might be right for
HIV I InfectionHIV Associated LipodystrophyMetabolic Syndrome+1 more
University of Novi Sad 120
Not applicableStudy completedNCT00106795
What this trial is testing

Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS

Who this might be right for
HIV InfectionsFatigueHIV Positive+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 82
Not applicableWithdrawnNCT01788462
What this trial is testing

Egrifta Replacement and Sleep Disordered Breathing

Who this might be right for
Lipodystrophy
Johns Hopkins University
Post-approval studies (Phase 4)Study completedNCT00202228
What this trial is testing

Lactate Metabolism Study in HIV Infected Persons

Who this might be right for
HIV InfectionsAIDSLactic Acidosis+1 more
Queen's University 30
Load More Results